Average
Based on 19 reviews
BraveRX3.9Honesty, pricing, process and quality scores appear once 5 customers have rated them.
BraveRX.com is a telemedicine platform that connects men with a licensed US physicians to access prescription treatments without the hassle of in-person doctor's visits. BraveRX Surge Max is a powerful 3-in-1 treatment that combines sildenafil and tadalafil to charge blood flow, and apomorphine to enhance arousal and intimacy. Plus, it works up to 5x faster than traditional ED pills by dissolving under your tongue, allowing the medicine to enter directly into your bloodstream. BraveRX is the future of erectile function, delivering a convenient process, 100% online, delivered fast and discreetly.
BraveRX (braverx.com) has 19 customer reviews on Folks Told, with an average rating of 3.9 out of 5.
Showing 12 reviews with 5 stars · Clear filters
Robert Daryl Y.
They are responsive.
Reply from BraveRXOct 21, 2025
Thank you for sharing your feedback. We’re truly sorry to hear about your experience and appreciate you letting us know. As a courtesy, we re-shipped your order and issued a 50% refund. Let us know if there is anything else we can do to make this right.
Kurt G.
The medication was very powerful and perfect for what i needed. The doctor visit was seamless and they were very professional. I've been on treatment now for 6 months and couldn't be happier
Reply from BraveRXJul 22, 2025
Thank you so much for the kind words, we really appreciate the feedback.
DJ
Was impressed with my results. Had longer erections but also could feel a slight uptick in clarity and mental performance at work. Really enjoy the product overall. They have a customer for life!
Reply from BraveRXMar 13, 2025
Very happy to add you to our fast-growing list of satisfied customers!
James W.
Been taking BraveRX Pro (daily) for almost 2 months now. It has given me tremendous confidence and has enhanced my drive. I've recommended it to a few friends as well, who have also had VERY positive experiences.
Reply from BraveRXJan 31, 2025
James, we appreciate the kind words!
